KZR
Kezar Life Sciences·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural
Analysts uniformly rate KZR neutral, offering no clear direction. Fund flow is strong (7.33/10), with overall, block and small investors net inflows, while medium and large investors show outflows. Positive money flow offsets neutral analyst stance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Derek ArchilaNeutral
Date2025-10-17
InstitutionWells Fargo
Times predicted1
Historical Win Rate100.0%
Matthew Christopher PhippsNeutral
Maury RaycroftNeutral
What is the market sentiment for KZR?
- KZR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).
